Please assess the completion status of the following clinical trial:

Trial Title: A Phase II/III Study of Continuous Local Anesthetic Infusion in Median Sternotomy Following Cardiac Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Be greater than 18 years of age~2. Be undergoing a cardiac surgical procedure via median sternotomy (i.e., exclude the occasional thoracotomy, since much greater pain with that surgical approach post-operatively)~Exclusion Criteria:~1. Are unable to grant informed consent or comply with study procedure~2. Are undergoing emergency open heart-surgery~3. Allergic to any of the excipients in ropivacaine, propofol, and fentanyl~4. Age \< 18 years of age (children have dosing and toxicity concerns)~5. Are pregnant (pregnancy changes pain thresholds)~6. Taking preoperative opioids. (Opioid tolerant patients will require significantly more post-operative opioid use.)~7. Cirrhosis or hepatic failure (may have accumulation of local anesthetic in plasma due to decreased metabolism)~8. Patient receiving lidocaine infusion prior to surgery. (An extremely rare event)~9. Patients having a planned circulatory arrest for their surgical procedure (increased duration of intubation possible)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Ropivicaine infusion into the sternal wound
- 2 (Type: PLACEBO_COMPARATOR): Normal saline infusion into the sternal wound

Based on this trial design, predict the completion outcome and termination type (if applicable).